Dr. Mohamad Takwa is co-founder and CEO of Epigenica, a biotech company developing breakthrough technology in epigenetic screening. Dr. Takwa is an academic, entrepreneur, investor and a strategic, creative visionary with long experience co-founding successful start-ups. As a serial-biotech entrepreneur he has co-founded, led, and successfully exited four innovative biotech and MedTech ventures (two M&As and two listings on the Swedish exchange market). 

He has a true passion for building innovation, driving personalized medicine and leading through fast-paced, complex changing ecosystems and integrations. Mohamad’s goal is to contribute to bringing the world novel, cost-effective and simple healthcare solutions, and he is particularly keen on building the case for prevention, open science, and epigenomics. He has extensive global experience across academic, business and clinical institutions, and enjoys sharing his experiences with the Boards he sits on as well as companies he provides strategic advice to.

Dr. Mohamad Takwa received a Ph.D. in Biotechnology from the Royal Institute of Technology (KTH) in Stockholm, an MSc in Molecular biotechnology from the University of Milano, was a Postdoctoral Fellow at Lund University.